Lessons in Orthopaedic Leadership: An AOA Podcast

Unlock the future of orthopaedic surgery as Arun Aneja, MD, PhD, a trailblazer in trauma surgery, unveils groundbreaking advancements in surgical implants. Explore how technology is reshaping the field with fourth-generation intramedullary nails and antibiotic-coated implants that promise to treat complex fractures and minimize complications. Discover the innovative biphasic plates designed to adapt dynamically to the healing needs of fractures, offering a glimpse into a more personalized approach to patient care. Dr. Aneja's pioneering insights reveal the transformative potential of these technologies, redefining the landscape of orthopaedic trauma surgery, one innovation at a time.
Delve into crucial topics such as antibiotic stewardship in orthopaedic procedures, where Dr. Aneja emphasizes the importance of responsible usage to combat resistance. Learn about the cutting-edge attachment of antibiotics to implants for sustained release and the use of growth factors to enhance bone healing. Consider the balance between the benefits of emergent technologies and their financial implications on healthcare systems. This episode serves as an enlightening journey through the latest orthopaedic innovations, offering listeners a detailed look into the exciting trajectory of trauma surgery and its future implications.

Brandi Hartley, MD FAOA joins AOA hosts Charles A. Goldfarb, MD, FAOA, and Alexander Aleem, MD to discuss away rotations.
Dr. Hartley shares her experience as Residency Program Director for University of Louisville's to discuss topics such as:

• Importance of away rotations
• Virtual rotation recruitment sessions and Zoom fatigue
• Decreased applicant numbers and students backing out of externships
• COPA's recommendations to eliminate away rotations
• The future of away rotations

Music:
Special thanks to Peter Martin of Peter Martin Music, Inc (@iampetermartin) for the jazz introduction and conclusion.

Tamara Scerpella, MD, Christina Morganti, MD, and Andrea Spiker, MD are back to join AOA hosts Charles A. Goldfarb, MD, FAOA, and Alexander Aleem, MD for the second part of their discussion on bone health in Sports Medicine and osteoporosis in younger athletes.
Drs. Scerpella, Morganti, and Spiker draw on their extensive experiences as athletes and as experts in sports medicine to discuss topics including :

• DEXA scans for younger patients
• Stress fractures vs. stress reactions
• Vitamin D supplementation
• Teriparatide use in younger patients

Music:
Special thanks to Peter Martin of Peter Martin Music, Inc (@iampetermartin) for the jazz introduction and conclusion.

Hosts Charles A. Goldfarb, MD, FAOA and Emerging Leader, Alexander W. Aleem, MD, talk with Daniel B. Murrey, MD, MPP, FAOA, Chief Medical Officer for Surgical Care Affiliates and President, Optum Specialty Practices about his symposium for the Virtual AOA Annual Meeting, Can We Align Conflicting Agendas: Medical Education and Value-Based Care.
With the focus on performance-based contracts by Medicare, Medicaid, and other payors, value-based care is taking hold at varying rates across the United States. The training of residents and fellows is often in direct conflict with this direction. The expert panel addresses questions regarding balancing the conflicting agendas of medical education of residents and fellows and the move toward value-based care.
Special thanks to Peter Martin of Peter Martin Music, Inc (@iampetermartin) for the jazz introduction and conclusion.
www.aoassn.org

Trends and Innovations in Orthopaedics: A CEO’s Perspective

Hosts Charles A. Goldfarb, MD, FAOA and Alexander Aleem, MD sit down with Cheryl Blanchard, BS, MS, PhD, president and CEO of Anika Therapeutics, to discuss how the company is driving technological innovations to benefit patients, orthopaedic surgeons, payors, and health care organizations.

Dr. Blanchard discusses how new orthopaedic trends impact the development process and shape product offerings. She describes how the 2020 acquisitions of Arthrosurface and Parcus Medical have dramatically shortened Anika’s innovation cycles to deliver greater value to physicians, patients, and shareholders.

The conversation touches on Dr. Blanchard’s career journey, merging her expertise in medicine, engineering, and business to becoming a leader of a multi-national orthopaedics corporation. She provides perspectives on challenging yourself professionally, including experiencing new things and not being afraid to accept a challenge.

Dr. Blanchard assumed the role of Anika’s president and chief executive officer in April 2020. She has served as president and CEO of Microchips Biotech, held senior executive positions at Zimmer-Biotech, and provided strategic consulting services to medical device companies and private equity clients. Dr. Blanchard currently serves as director of Vigil Neuroscience and Daré Bioscience. Dr. Blanchard received her M.S. and Ph.D. in Materials Science and Engineering from the University of Texas at Austin and received her B.S. in Ceramic Engineering from Alfred University.

Anika (NASDAQ: ANIK) is a global joint preservation company committed to delivering meaningful advancements in early intervention orthopedic care, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies.